Jazz, in the hunt for new FDA nod, schools doctors on rare excessive sleepiness disorder

Jazz, in the hunt for new FDA nod, schools doctors on rare excessive sleepiness disorder

Source: 
Fierce Pharma
snippet: 

Sleep disorders often go unrecognized—and untreated. Jazz Pharmaceuticals wants to change that with a new awareness campaign targeting physicians for rare condition idiopathic hypersomnia.


The "I Have IH" campaign, created in partnership with the Hypersomnia Foundation, began after research found 90% of healthcare providers said they needed more education when it comes to diagnosing idiopathic hypersomnia.